Klotho Neurosciences, Inc. (KLTO)
NASDAQ: KLTO · Real-Time Price · USD
0.2957
-0.0256 (-7.97%)
Jan 14, 2026, 12:59 PM EST - Market open
Klotho Neurosciences Market Cap
Klotho Neurosciences has a market cap or net worth of $21.74 million as of January 14, 2026. Its market cap has increased by 121.83% in one year.
Market Cap
21.74M
Enterprise Value
16.28M
1-Year Change
121.83%
Ranking
Category
Stock Price
$0.30
Market Cap Chart
Since April 29, 2022, Klotho Neurosciences's market cap has decreased from $127.33M to $21.74M, a decrease of -82.92%. That is a compound annual growth rate of -37.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 23.63M | 12.71% |
| Dec 31, 2025 | 20.96M | 103.27% |
| Dec 31, 2024 | 10.31M | -89.05% |
| Dec 22, 2023 | 94.18M | -37.22% |
| Dec 20, 2022 | 150.02M | 17.82% |
| Apr 29, 2022 | 127.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.49B |
| Johnson & Johnson | 514.75B |
| AbbVie | 390.15B |
| UnitedHealth Group | 302.49B |
| AstraZeneca | 291.77B |
| Novartis AG | 272.12B |
| Merck & Co. | 268.70B |
| Novo Nordisk | 265.30B |